Aug 11, 2026

Circleback CEO Ali Haghani: Recording Company Meetings Will Become The Norm

Ali Haghani, co-founder of CircleBack, shares his unique hardware setup and delves into how his AI notetaker streamlines business operations, from interview tracking to customer support. He discusses the shift from manual coding to AI-orchestrated development, the nuances of prompt engineering, and his vision for why recording meetings with AI is becoming essential for leveraging LLMs and agents effectively in enterprises, ultimately reshaping the future of software engineering.

Aug 11, 2026

The Past, Present & Future of Programming Languages • Kevlin Henney • YOW! 2025

Kevlin Henney explores the slow but profound evolution of programming languages, revealing how many 'new' features are decades-old concepts. He analyzes language popularity rankings, highlighting the dominance of 20th-century languages and the impact of the "von Neumann bottleneck." The talk delves into historical innovations from Fortran to Algol, coroutines to functional programming, and concludes by examining how Large Language Models (LLMs) are becoming clients of existing languages, further entrenching the mainstream rather than causing radical change, often due to their training data favoring established codebases.

Aug 10, 2026

5 Best Practices for Building AI Agent Skills

This video outlines five essential best practices for developing reliable, secure, and effective AI agent skills. It covers optimizing skill triggering through descriptive metadata, leveraging real-world domain expertise over generic LLM output, managing context windows efficiently by writing lean skills and using progressive disclosure, implementing deterministic logic with scripts for fragile operations, and critically vetting all skills for security vulnerabilities before deployment. These practices are crucial for professionals building robust agentic systems.

Aug 07, 2026

The New Primitives: Building AI Native Software — Kwindla Kramer, Daily

Kwindla Hultman Kramer argues that current AI agents are akin to 1995 web pages – a foundational primitive, not the ultimate destination. Drawing a historical parallel, he predicts the emergence of "AI native software" that will build upon and surpass agents, much like web applications evolved from simple web pages. He illustrates this through computing history, highlighting transformative shifts like VisiCalc's impact on accounting and the vision of Apple's Knowledge Navigator, and concludes by showcasing a game, Gradient Bang, that demonstrates the core primitives of this future AI native software.

Aug 06, 2026

The State of Model Routing — NVIDIA, Cognition, OpenRouter

A deep dive into model routing strategies for AI/ML production, featuring experts from Cognition, OpenRouter, and NVIDIA. Key topics include optimizing costs with multi-model systems, delegating tasks between frontier and smaller models, managing context efficiently (sidekicks, compaction), and adapting to dynamic task complexities. The panel discusses the fragility of naive routing, the cost implications of in-distribution vs. out-of-distribution tasks, and the evolution of auto-routers driven by real-world usage patterns like OpenClaw's heartbeats. Insights also cover NVIDIA's Flex Run for dynamic model sizing, hallucination probes for detecting model limitations, and the future of hybrid local/cloud routing and model collaboration.

Aug 04, 2026

How AI Helps Solve Medical Mysteries at Boston Children’s Hospital | OpenAI Forum

Researchers from Boston Children's Hospital and OpenAI collaborated to apply AI (specifically, OpenAI o3 Deep Research) to tackle the "diagnostic odyssey" of rare diseases. By analyzing complex genomic and phenotypic data, the AI model helped identify 18 new diagnoses in 376 previously unsolved pediatric cases, showcasing its ability to accelerate literature review, generate hypotheses, and uncover obscure but critical information. This human-in-the-loop approach aims to make diagnosis faster, more accessible, and more precise, offering hope for personalized medicine and improved patient outcomes.